Biosynthetic neoantigen displayed on bacteria derived vesicles elicit systemic antitumour immunity
Open Access
- 5 December 2022
- journal article
- research article
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 11 (12) , e12289
Abstract
Neoantigens derived from mutant proteins in tumour cells could elicit potent personalized anti‐tumour immunity. Nevertheless, the layout of vaccine vehicle and synthesis of neoantigen are pivotal for stimulating robust response. The power of synthetic biology enables genetic programming bacteria to produce therapeutic agents under contol of the gene circuits. Herein, we genetically engineered bacteria to synthesize fusion neoantigens, and prepared bacteria derived vesicles (BDVs) presenting the neoantigens (BDVs‐Neo) as personalized therapeutic vaccine to drive systemic antitumour response. BDVs‐Neo and granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) were inoculated subcutaneously within hydrogel (Gel), whereas sustaining release of BDVs‐Lipopolysaccharide (LPS) and GM‐CSF recruited the dendritic cells (DCs). Virtually, Gel‐BDVs‐Neo combined with the programmed cell death protein 1 (PD‐1) antibody intensively enhanced proliferation and activation of tumour‐infiltrated T cells, as well as memory T cell clone expansion. Consequently, BDVs‐Neo combining with checkpoint blockade therapy effectively prevented tumour relapse and metastasis.Keywords
This publication has 56 references indexed in Scilit:
- Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscaleCurrent Opinion in Biotechnology, 2014
- Bioengineered Bacterial Outer Membrane Vesicles as Cell-Specific Drug-Delivery Vehicles for Cancer TherapyACS Nano, 2014
- Lipoproteins of Bacterial PathogensInfection and Immunity, 2011
- Vaccine delivery: a matter of size, geometry, kinetics and molecular patternsNature Reviews Immunology, 2010
- Biological Functions and Biogenesis of Secreted Bacterial Outer Membrane VesiclesAnnual Review of Microbiology, 2010
- Proteomics in gram‐negative bacterial outer membrane vesiclesMass Spectrometry Reviews, 2008
- Cancer Vaccines: Preclinical Studies and Novel Strategies2006
- Bacterial outer membrane vesicles and the host–pathogen interactionGenes & Development, 2005
- Dendritic cells as therapeutic vaccines against cancerNature Reviews Immunology, 2005
- Lymphocyte-Mediated CytotoxicityAnnual Review of Immunology, 2002